Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | MicroRNA (Shariqah, United Arab Emirates) | journal | 1.296 Q1 | 29 | 0 | 18 | 0 | 116 | 16 | 0.00 | 0.00 | 0.00 | |
2 | Current Neuropharmacology | journal | 1.168 Q1 | 103 | 156 | 307 | 20941 | 1976 | 293 | 5.03 | 134.24 | 43.51 | |
3 | Current Protein and Peptide Science | journal | 0.612 Q2 | 96 | 74 | 299 | 6244 | 966 | 277 | 2.58 | 84.38 | 41.01 | |
4 | CNS and Neurological Disorders - Drug Targets | journal | 0.574 Q2 | 96 | 81 | 217 | 8156 | 639 | 205 | 2.86 | 100.69 | 38.48 | |
5 | Mini-Reviews in Medicinal Chemistry | journal | 0.570 Q2 | 107 | 162 | 450 | 17321 | 1925 | 442 | 3.98 | 106.92 | 41.82 | |
6 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.558 Q2 | 52 | 35 | 97 | 3255 | 293 | 92 | 2.72 | 93.00 | 50.89 | |
7 | Current Stem Cell Research and Therapy | journal | 0.552 Q2 | 63 | 63 | 235 | 5371 | 704 | 221 | 2.36 | 85.25 | 40.77 | |
8 | Current Cardiology Reviews | journal | 0.536 Q2 | 58 | 63 | 156 | 4269 | 404 | 146 | 1.78 | 67.76 | 23.53 | |
9 | Current Topics in Medicinal Chemistry | journal | 0.516 Q2 | 133 | 191 | 680 | 19008 | 1979 | 550 | 2.79 | 99.52 | 43.40 | |
10 | Reviews on Recent Clinical Trials | journal | 0.377 Q3 | 35 | 46 | 136 | 1902 | 226 | 119 | 1.60 | 41.35 | 41.61 | |
11 | Recent patents on food, nutrition & agriculture | journal | 0.354 Q3 | 33 | 0 | 59 | 0 | 141 | 55 | 2.67 | 0.00 | 0.00 | |
12 | Recent Advances in Drug Delivery and Formulation | journal | 0.347 Q3 | 41 | 23 | 58 | 1876 | 145 | 52 | 1.80 | 81.57 | 48.91 | |
13 | Infectious Disorders - Drug Targets | journal | 0.298 Q3 | 61 | 100 | 328 | 4928 | 482 | 311 | 1.40 | 49.28 | 43.11 | |
14 | Current Nanoscience | journal | 0.284 Q3 | 52 | 64 | 236 | 5132 | 387 | 228 | 1.65 | 80.19 | 36.89 | |
15 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.280 Q3 | 27 | 18 | 87 | 1262 | 138 | 82 | 1.36 | 70.11 | 46.59 | |
16 | Combinatorial Chemistry and High Throughput Screening | journal | 0.271 Q3 | 70 | 227 | 359 | 11817 | 560 | 333 | 1.65 | 52.06 | 40.67 | |
17 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.270 Q3 | 45 | 29 | 106 | 1316 | 124 | 100 | 1.09 | 45.38 | 27.59 | |
18 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.268 Q3 | 43 | 26 | 55 | 1492 | 98 | 49 | 1.37 | 57.38 | 38.14 | |
19 | Current Computer-Aided Drug Design | journal | 0.258 Q3 | 32 | 42 | 195 | 1983 | 312 | 187 | 1.66 | 47.21 | 45.93 | |
20 | Current Nanomedicine | journal | 0.212 Q4 | 8 | 17 | 38 | 1475 | 37 | 37 | 0.97 | 86.76 | 36.07 | |
21 | Open Biomarkers Journal | journal | 0.182 Q4 | 7 | 10 | 33 | 428 | 25 | 33 | 0.29 | 42.80 | 61.70 | |
22 | Open Biomedical Engineering Journal | journal | 0.163 Q4 | 28 | 5 | 51 | 282 | 40 | 48 | 0.64 | 56.40 | 27.27 | |
23 | Sudan Journal of Medical Sciences | journal | 2 | 52 | 0 | 1294 | 0 | 0 | 0.00 | 24.88 | 36.17 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®